Biodegradable Hydrophobic Injectable Polymers for Drug Delivery and Regenerative Medicine

被引:50
作者
Arun, Yuvaraj [1 ,2 ]
Ghosh, Radhakanta [1 ,2 ]
Domb, Abraham J. [1 ,2 ]
机构
[1] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med,Alex Grass Ctr Drug Design & Synth, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Ctr Cannabis Res, IL-91120 Jerusalem, Israel
基金
以色列科学基金会;
关键词
biomaterials; drug delivery; hydrophobic polymers; injectable polymers; regenerative medicine; IN-VITRO; BIOMEDICAL APPLICATIONS; HYDROLYTIC DEGRADATION; EPSILON-CAPROLACTONE; SUSTAINED-RELEASE; RHEOLOGICAL PROPERTIES; EXTENDED-RELEASE; VISCOUS-LIQUID; LACTIC ACID; TISSUE;
D O I
10.1002/adfm.202010284
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Biodegradable, hydrophobic, and injectable liquid polymers are capable of achieving the minimally invasive, sustained, and local release of drugs. These hydrophobic injectable polymers also have potential in the area of regenerative medicine where the biomaterial should be stable for a certain period and then degrade to allow the growth of cells/tissues. This review presents exclusive coverage of biocompatible hydrophobic injectable pasty or liquid polymers that can be injected without the use of any solvent for drug delivery, tissue augmentation, and regenerative medicine application. The synthesis methodologies of several major types of hydrophobic pasty polymers used in the biomedical fields and their properties with the foremost criteria to serve as injectable biomaterial for localized drug delivery and regenerative medicine is described. The hydrophobic biodegradable injectable polymers discussed are aliphatic polyesters, polycarbonates and polyanhydrides, prepared from: lactic acid, glycolic acid, caprolactone, aliphatic diols and diacids, hydroxy fatty acids, and triglycerides such as castor oil.
引用
收藏
页数:22
相关论文
共 134 条
[1]   Modified double emulsion process as a new route to prepare submicron biodegradable magnetic/polycaprolactone particles for in vivo theranostics [J].
Ahmed, Naveed ;
Michelin-Jamois, Millan ;
Fessi, Hatem ;
Elaissari, Abdelhamid .
SOFT MATTER, 2012, 8 (08) :2554-2564
[2]   Development of biodegradable injectable thermoplastic oligomers [J].
Amsden, B ;
Hatefi, A ;
Knight, D ;
Bravo-Grimaldo, E .
BIOMACROMOLECULES, 2004, 5 (02) :637-642
[3]   Liquid, Injectable, Hydrophobic and Biodegradable Polymers as Drug Delivery Vehicles [J].
Amsden, Brian G. .
MACROMOLECULAR BIOSCIENCE, 2010, 10 (08) :825-835
[4]   VEGF-induced angiogenesis following localized delivery via injectable, low viscosity poly(trimethylene carbonate) [J].
Amsden, Brian G. ;
Timbart, Laurianne ;
Marecak, Dale ;
Chapanian, Rafi ;
Tse, M. Yat ;
Pang, Stephen C. .
JOURNAL OF CONTROLLED RELEASE, 2010, 145 (02) :109-115
[5]   Polylactide Stereocomplexation Leads to Higher Hydrolytic Stability but More Acidic Hydrolysis Product Pattern [J].
Andersson, Sofia Regnell ;
Hakkarainen, Minna ;
Inkinen, Saara ;
Sodergard, Anders ;
Albertsson, Ann-Christine .
BIOMACROMOLECULES, 2010, 11 (04) :1067-1073
[6]  
[Anonymous], 2014, FOCAL CONTROLLED DRU, DOI DOI 10.1186/1687-4153-2014-3
[7]  
Armentano I, 2015, RSC CATAL SER, P266
[8]   Injectable formulations for an intravitreal sustained-release application of a novel single-chain VEGF antibody fragment [J].
Asmus, Lutz R. ;
Grimshaw, John P. A. ;
Richle, Philipp ;
Eicher, Barbara ;
Urech, David M. ;
Gurny, Robert ;
Moeller, Michael .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 :250-260
[9]   Corelease of Bioactive VEGF and HGF from Viscous Liquid Poly(5-ethylene ketal ε-caprolactone-co-D,L-lactide) [J].
Babasola, Iyabo Oladunni ;
Rooney, Meghan ;
Amsden, Brian G. .
MOLECULAR PHARMACEUTICS, 2013, 10 (12) :4552-4559
[10]   Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: Potential and mechanism [J].
Babasola, Iyabo Oladunni ;
Zhang, Wei ;
Amsden, Brian G. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) :765-772